This investigation is aimed at elucidating the association between Lp‐PLA2 activity and CTRP‐3 concentrations and CVD events, specifically, cardiovascular or cerebrovascular mortality, acute coronary syndromes, and coronary stent implantation, in patients with T2DM. This evidence concerns the gene PLA2G7 and type 2 diabetes mellitus.